Last reviewed · How we verify
Placebo of Simvastatin — Competitive Intelligence Brief
phase 3
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Simvastatin (Placebo of Simvastatin) — Tanabe Pharma Corporation. This is a placebo control formulation used in clinical trials to compare against the active simvastatin drug and has no therapeutic mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Simvastatin TARGET | Placebo of Simvastatin | Tanabe Pharma Corporation | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Simvastatin CI watch — RSS
- Placebo of Simvastatin CI watch — Atom
- Placebo of Simvastatin CI watch — JSON
- Placebo of Simvastatin alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Simvastatin — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-simvastatin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab